Jing Fang

Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells

G. Jin, Yong Lu, Gang Xue, 2021, Nature Biomedical Engineering.

Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.

Guojun Wu, Yan-jun Ma, Tai-ming Li, 2009, Vaccine.

Specific Antibodies Elicited by a Novel DNA Vaccine Targeting Gastrin-Releasing Peptide Inhibit Murine Melanoma Growth In Vivo

Guojun Wu, Yingying Chen, Tai-ming Li, 2009, Clinical and Vaccine Immunology.

Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance.

G. Jin, G. McFadden, Yong Lu, 2022, Cancer cell.

IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling

G. Jin, Yong Lu, Gang Xue, 2019, Nature Communications.

Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells.

G. Jin, G. Dotti, Q. Yi, 2021, Cancer cell.

IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling

Guangxu Jin, Yong Lu, G. Jin, 2019, Nature Communications.

Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy.

M. Abdelrahim, Gang Xue, Jing Fang, 2024, Cancer cell.